Literature DB >> 30336792

Angiogenic T cells in primary Sjögren's syndrome: a double-edged sword?

Alessia Alunno1, Lidia Ibba-Manneschi2, Onelia Bistoni1, Sabrina Cipriani1, Fabiana Topini1, Roberto Gerli1, Mirko Manetti3.   

Abstract

OBJECTIVES: The mechanisms underlying increased cardiovascular risk in primary Sjögren's syndrome (pSS) remain unclear. Since the recently discovered angiogenic T cells (Tang) may participate in endothelial repair by cooperating with endothelial progenitor cells (EPC), we aimed to quantify and characterise Tang in the peripheral blood and minor salivary glands (MSG) of pSS patients.
METHODS: Tang (CD3+CD31+CXCR4+) and EPC (CD34+CD133+VEGFR-2+) were quantified by flow cytometry in peripheral blood samples from 36 pSS patients and 20 healthy donors. Tang subsets were assessed on the basis of CD4, CD8 and CD28 expression. Labial MSG sections from 10 pSS patients and 12 non-pSS sicca syndrome controls were subjected to immunofluorescence staining to investigate the presence of Tang and the expression of the CXCR4-ligand stromal cell-derived factor-1 (SDF-1)/CXCL12.
RESULTS: Circulating Tang cells were expanded and directly correlated to EPC in pSS. Both Tang and EPC directly correlated with disease activity as calculated with the EULAR Sjögren's syndrome disease activity index (ESSDAI). In pSS, the majority of Tang cells were CD4-CD8- double negative (DN) and lacked CD28 revealing a senescent phenotype. A subset of CD4+, CD8+ and DN Tang cells produced interleukin-17. Immunohistology revealed the exclusive presence of periductal and perivascular infiltrating Tang cells along with increased SDF-1/CXCL12 expression in pSS MSG compared to non-pSS sicca syndrome controls.
CONCLUSIONS: In pSS, Tang cells are expanded in peripheral blood and infiltrate MSG. Tang may be novel actors in pSS-related endothelial dysfunction and glandular neo-angiogenesis and inflammation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30336792

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  Cardiovascular Involvement in Sjögren's Syndrome.

Authors:  Fabiola Atzeni; Francesco Gozza; Giacomo Cafaro; Carlo Perricone; Elena Bartoloni
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 2.  T Cells Subsets in the Immunopathology and Treatment of Sjogren's Syndrome.

Authors:  William de Jesús Ríos-Ríos; Sorely Adelina Sosa-Luis; Honorio Torres-Aguilar
Journal:  Biomolecules       Date:  2020-11-11

3.  Integrated proteome and phosphoproteome analyses of peripheral blood mononuclear cells in primary Sjögren syndrome patients.

Authors:  Shaoying Huang; Fengping Zheng; Lixiong Liu; Shuhui Meng; Wanxia Cai; Cantong Zhang; Weier Dai; Dongzhou Liu; Xiaoping Hong; Donge Tang; Yong Dai
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

4.  Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?

Authors:  Verónica Pulito-Cueto; Sara Remuzgo-Martínez; Fernanda Genre; Belén Atienza-Mateo; Víctor M Mora-Cuesta; David Iturbe-Fernández; Leticia Lera-Gómez; Javier Rodriguez-Carrio; Diana Prieto-Peña; Virginia Portilla; Ricardo Blanco; Alfonso Corrales; Oreste Gualillo; José M Cifrián; Raquel López-Mejías; Miguel A González-Gay
Journal:  Biomedicines       Date:  2022-04-05

5.  Vaginal dryness in primary Sjögren's syndrome: a histopathological case-control study.

Authors:  Jolien F van Nimwegen; Karin van der Tuuk; Silvia C Liefers; Gwenny M Verstappen; Annie Visser; Robin F Wijnsma; Arjan Vissink; Harry Hollema; Marian J E Mourits; Hendrika Bootsma; Frans G M Kroese
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.